
Galapagos NV GLPG.AS reported quarterly adjusted earnings of 38 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of €2.39. The mean expectation of three analysts for the quarter was for a loss of 69 cents per share. Wall Street expected results to range from €-1.29 to -34 cents per share.
Revenue fell 77.4% to €75.50 million from a year ago; analysts expected €83.94 million.
Galapagos NV's reported EPS for the quarter was 38 cents.
The company reported quarterly net income of €25.31 million.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 7 "hold" and 3 "sell" or "strong sell."
The average consensus recommendation for the biotechnology & medical research peer group is also "hold"
Wall Street's median 12-month price target for Galapagos NV is €29.50
This summary was machine generated from LSEG data February 12 at 10:02 p.m. UTC. All figures in euros unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Dec. 31 2024 | -0.69 | 0.38 | Beat |
Sep. 30 2024 | -0.49 | -0.77 | Missed |
Jun. 30 2024 | -0.21 | 0.14 | Beat |
Mar. 31 2024 | -0.14 | 1.37 | Beat |